[1]
F. Saboor and J. Lu, “Conversion and Neoadjuvant Therapy for Intrahepatic Cholangiocarcinoma: Integrating Precision Medicine to Redefine Surgical Curability”, JGLD, vol. 35, no. 3, pp. 469–481, Jul. 2026.